ScholarLens Back to search
2021•PubMedRequires access

[Hypomethylation of DAPL1 associated with prognosis of lung cancer patients with EGFR Del19 mutation].

Y Y Feng, Yinxue Yang, Y Y Wang, Xuehong Bai, Ping Hai, Ren Zhao

Open publisher page 3 citations

Abstract

High DAPL1 expression, or hypomethylation, is associated with lung cancer EGFR Del19 mutation subtype, and DAPL1 hypomethylated lung cancer patients have longer overall survival.

About this research paper

What this paper is about

High DAPL1 expression, or hypomethylation, is associated with lung cancer EGFR Del19 mutation subtype, and DAPL1 hypomethylated lung cancer patients have longer overall survival.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

High DAPL1 expression, or hypomethylation, is associated with lung cancer EGFR Del19 mutation subtype, and DAPL1 hypomethylated lung cancer patients have longer overall survival.

Key concepts: Lung cancer, Adenocarcinoma, Oncology, Medicine, Internal medicine, Survival analysis, Epidermal growth factor receptor, Lung

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
[Hypomethylation of DAPL1 associated with prognosis of lung cancer patients with EGFR Del19 mutation]. — Research Paper | ScholarLens